课题基金 / 基金详情

Research for molecular mechanisms of lymphangiogenesis and lymph node metastasis

Research for molecular mechanisms of lymphangiogenesis and lymph node metastasis
淋巴管生成及淋巴结转移的分子机制研究
批准号:
16390378
负责人:
KUBO Hajime
金额:
$9.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

KUBO Hajime的其他基金

相似基金

相关文献

中文摘要
翻译
1.淋巴标志物Podoplan in在肿瘤中的表达与淋巴结转移密切相关,我们建立了新型的抗人Podoplan in抗体,并利用组织芯片技术发现了其在多种癌细胞中的表达。2.同源盒基因PROX1是一个新的肿瘤抑制基因,我们发现PROX1的表达与肿瘤分化程度密切相关。随后,我们还发现PROX1在肿瘤中的低表达与预后不良密切相关。3.两组Thy1阳性的间充质细胞调节肝祖细胞的体外成熟。我们确定粘蛋白跨膜型糖蛋白gp38可以区分立方细胞和Spin…免疫细胞化学显示更多的中间细胞。Gp38阳性细胞促进的肝祖细胞体外成熟可能受到gp38阴性细胞的抑制作用,这可能维持了CD49f阳性细胞的未成熟的增殖状态。4.胚胎干细胞和淋巴管内皮细胞对OP9基质细胞的分化分化第3天由ES细胞分化为LEC的VEGFR-2^+细胞与OP9基质细胞的分化由PROX1、VEGFR-3和另一淋巴标志物podoplan in的表达决定。VEGFR-2^+细胞分化为LYVE-1~+胚胎ECs,第1天PROX1阴性,第3天转为PROX1~+LECs。VEGFR3-Fc或Tie2-Fc,封闭血管内皮生长因子-C或血管生成素1(Ang1),抑制晶状体上皮细胞在OP9细胞上的集落形成。然而,在胶原包被的培养皿中加入血管内皮生长因子-C和血管紧张素1,联合应用于VEGFR-2^+细胞,并不能诱导晶状体上皮细胞。用该条件培养液在PFA固定的OP9细胞上完全复制了OP9细胞的LEC诱导活性。较少
英文摘要
1.The expression of lymphatic marker, podoplanin by cancer were associated with the frequency of lymph node metastasis.We established novel anti-human podoplanin antibodies, and found the expression by several cancer cells using tissue microarrays. We also found that podoplanin was the specific marker for mesothelioma.2.Homeobox gene, prox1 as a novel tumor suppressor gene.We found that there was a significant correlation between prox1 expression and the differentiation scores of the tumors. Subsequently, we also showed that low expression of prox1 in tumors was closely associated with a poor prognosis. The specific knockdown of prox1 by RNA interference strongly accelerated in vitro cell growth, while the over-expression of prox1 greatly suppressed the growth.3.Two populations of Thy1-positive mesenchymal cells regulate the in vitro maturation of hepatic progenitor cellsWe determined that the mucin-type transmembrane glycoprotein gp38 could distinguish the cuboidal cells from the spin … More dle cells by immunocytochemistry. In vitro maturation of hepatic progenitor cells promoted by gp38-positive cells may be opposed by an inhibitory effect of gp38-negative cells, which likely maintain the immature, proliferative state of CD49f-positive cells.4.Differentiation of lymphatic endothelial cells from Embryonic Stem cells on OP9 stromal cellsVEGFR-2^+ cells derived from ES cells differentiated into LECs at day3 on OP9 stromal cells defined by the expression of prox1, VEGFR-3 and another lymphatic marker podoplanin. VEGFR-2^+ cells gave rise to LYVE-1^+ embryonic ECs, which were negative for prox1 on day1 but turned to prox1^+ LECs by day3. VEGFR3-Fc or Tie2-Fc, sequestering VEGF-C or angiopoietin 1 (Ang1), suppressed colony formation of LECs on OP9 cells. However, addition of VEGF-C and Ang1 in combination with VEGF to the culture of VEGFR-2^+ cells on collagen-coated dishes failed to induce LECs. LEC inducing activity of OP9 cells was fully reproduced on PFA-fixed OP9 cells with the conditioned medium. Less
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
All-trans retinoic acid modulates proliferation of lung fibroblasts via IL-6/IL-6R system.
全反式维A酸通过IL-6/IL-6R系统调节肺成纤维细胞的增殖。
DOI: --
发表时间: 2006
期刊: Am J Physiol Lung Cell Mol Physiol. 290
影响因子: --
作者: [Tabata C, Kubo H, Tabata R, Wada M, Sakuma K, Ichikawa M, Fujita S, Mio T, Mishima M]
通讯作者: Mishima M
DOI: 10.1111/j.1349-7006.2004.tb03211.x
发表时间: 2004-04
期刊: Cancer Science
影响因子: 5.7
作者: [K. Shimizu;H. Kubo;K. Yamaguchi;K. Kawashima;Y. Ueda;Koichi Matsuo;M. Awane;Y. Shimahara;]
通讯作者: K. Shimizu;H. Kubo;K. Yamaguchi;K. Kawashima;Y. Ueda;Koichi Matsuo;M. Awane;Y. Shimahara;
Molecular mechanisms of lymphangiogenesis in diseases.
疾病中淋巴管生成的分子机制。
DOI: --
发表时间: 2004
期刊: Microcirculation annual. 20
影响因子: --
作者: [Kubo H., Kono T]
通讯作者: Kono T
DOI: 10.1097/01.pas.0000172192.25295.45
发表时间: 2005-10-01
期刊: AMERICAN JOURNAL OF SURGICAL PATHOLOGY
影响因子: 5.6
作者: [Kumasaka, T, Seyama, K, Suda, K]
通讯作者: Suda, K
Targeting therapy against cancer stem cells
  • 批准号:
    20390341
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $12.31万
  • 财政年份:
    2008
  • 负责人:
    KUBO Hajime
  • 依托单位:
Anovel mechanism of tumor progression by the candidate tumor suppressor Proxl : RNA mutation in cancer
  • 批准号:
    18390345
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.28万
  • 财政年份:
    2006
  • 负责人:
    KUBO Hajime
  • 依托单位:
Lymphangiogenesis in cancer
  • 批准号:
    17014047
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
  • 资助金额:
    $29.06万
  • 财政年份:
    2005
  • 负责人:
    KUBO Hajime
  • 依托单位:
海外基金